密歇根州阿片类药物立法与眼整形眼眶手术后阿片处方模式变化
2018年6月1日立法实施前手术的2026例中1782例(88.0%)被开具术后阿片类药物,实施后手术的1755例中878例(50.0%)被开具(P < .001)。线性插值样条回归显示2017年6月1日至2018年9月30日期间吗啡毫克当量(MME)减少26.025 MME(相当于平均MME降低36.2%),并在研究期末维持降低水平。
要点
- 密歇根州阿片立法实施后,眼整形眼眶手术后阿片处方比例从88.0%降至50.0%。
- 立法实施期间处方MME减少26.025 MME,相当于平均MME降低36.2%。
- 处方MME的降低在研究期末维持稳定,立法前后12个月内未见MME变化。
核心结论
- 在密歇根州阿片类药物立法实施期间,眼整形和眼眶手术的术后阿片处方减少,并持续至研究期末。
主要发现
- 2018年6月1日前手术的2026例中1782例(88.0%)被开具术后阿片类药物,之后手术的1755例中878例(50.0%)被开具(P < .001)。
- 两个队列在年龄、性别、种族/民族、手术类型或阿片处方方面无差异。
- 线性插值样条回归显示2017年6月1日至2018年9月30日期间MME减少26.025 MME(相当于平均MME降低36.2%;β,-1.735;95%CI,-0.088至-0.024;P < .001)。
- 立法实施前后12个月内未发现MME变化。
关键数值与推荐
- 2018年6月1日生效的立法要求处方者在开具阿片类药物前审查患者阿片使用史报告,并在教育患者使用和处置阿片后获得签署同意。
临床怎么用
- 类似旨在提高处方者意识和患者教育的州级或国家级立法可能有助于遏制处方阿片类药物流行。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Understanding whether statewide legislation, such as the Michigan Opioid Laws, is associated with reduction in postoperative opioid prescriptions is informative in guiding future legislation. OBJECTIVE: To identify changes in opioid prescribing patterns for oculoplastic and orbital procedures associated with the enactment of the Michigan Opioid Laws in 2017 and 2018. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study included 3781 patients who underwent any of 10 common oculoplastic and orbital procedures between June 1, 2016, and November 30, 2019, at a tertiary care institution. EXPOSURES: From 2017 to 2018, Michigan enacted a series of laws to address the state's worsening opioid epidemic. Two major components of this legislation enacted on June 1, 2018, required prescribers to review a report of patients' opioid use history and obtain signed consent after educating patients on the use and disposal of opioids prior to prescribing. MAIN OUTCOMES AND MEASURES: Demographic information, type of surgery, type and amount of opioid prescriptions, and morphine milligram equivalent (MME) were analyzed. MME was calculated as the product of dose, quantity, and opioid-specific conversion factor for each prescription. Linear interpolation spline regression was used to evaluate the association of prescription MME with time. RESULTS: Of 3781 patients, 1614 (42.7%) were male. The mean (SD) age at the time of surgery was 63.3 (16.6) years. Of 2026 patients undergoing surgery before June 1, 2018, 1782 (88.0%) were prescribed postoperative opioids; of 1755 patients undergoing surgery after June 1, 2018, 878 (50.0%) were prescribed postoperative opioids (P < .001). There was no difference in age, sex, race/ethnicity, surgery type, or opioids prescribed between these 2 cohorts. Linear interpolation spline regression showed a decrease of 26.025 MMEs (equivalent to a 36.2% reduction of mean MME) between June 1, 2017, and September 30, 2018 (β, -1.735; 95% CI, -0.088 to -0.024; P < .001), stabilizing at a persistently reduced rate of MME prescribed through the end of the study period (October 1, 2018, to November 30, 2019; β, -0.005; 95% CI, -0.039 to 0.016; P = .42). Changes in MME in the 12 months before or 12 months after the period of legislation enactment were not identified. CONCLUSIONS AND RELEVANCE: In this cross-sectional study, reduction in opioid prescriptions for oculoplastic and orbital procedures was observed during the enactment period of the Michigan Opioid Laws and appeared to be sustained through the end of the study period. Similar statewide or national legislations aimed at increasing prescriber awareness and patient education on opioid use may help curtail the prescription opioid epidemic.
引用
- Xie Y, Joseph AW, Rudy SF, et al. Change in Postoperative Opioid Prescribing Patterns for Oculoplastic and Orbital Procedures Associated With State Opioid Legislation. JAMA Ophthalmol. 2021. PMID: 33300973. doi:10.1001/jamaophthalmol.2020.5446
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。